PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-02-23

Date Title Company
23-Feb-2022 Darolutamide plus androgen deprivation therapy and docetaxel significantly increases overall survival in patients with metastatic hormone-sensitive prostate cancer Orion Corporation
23-Feb-2022 Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program Sanofi
23-Feb-2022 Results from an Ongoing Phase I/II CYPIDES Trial of ODM-208 Presented at ASCO-GU Orion Corporation
23-Feb-2022 Completion of sale of Gyroscope Therapeutics Syncona Ltd
23-Feb-2022 Almirall launches innovative Wynzora® CAL/BDP cream in Europe for the treatment of mild to moderate plaque psoriasis in adults including scalp Almirall
23-Feb-2022 Immutep to present new data from the phase II TACTI-002 study of efti at ESMO’s European Lung Cancer Congress 2022 Immutep Limited
23-Feb-2022 Dante Labs Partnering with The Renato Dulbecco Foundation to advance personalized medicines for cancer, COVID-19 and rare diseases Dante Labs
23-Feb-2022 High infliximab trough levels are associated with low risk of relapse when switching to subcutaneous infliximab in patients with inflammatory bowel disease, suggests new data presented at ECCO 2022 virtual congress Celltrion Healthcare
23-Feb-2022 MODERNA EXPANDS ITS MRNA PIPELINE WITH THREE NEW DEVELOPMENT PROGRAMS MODERNA
23-Feb-2022 Dr. Jorge Gallardo Ballart announces his intention to retire from his positions of President of the Board of Directors and Board member of Almirall Almirall, S.A. (ALM)
23-Feb-2022 Half-Year Results for the Six Months Ended 31 December 2021 and Notice of Investor Presentation Sareum Holdings plc
23-Feb-2022 NHS gene testing does not detect half of people at cancer risk The Institute of Cancer Research, London
23-Feb-2022 US$100M VC Fund True Global Ventures injects US$8.3 million funding to US-based Chronicled to automate Healthcare Industry True Global Ventures 4 Plus
23-Feb-2022 4D pharma announces FDA clearance of IND application for Live Biotherapeutics MRx0005 and MRx0029 for the treatment of Parkinson’s disease 4D pharma
23-Feb-2022 Oxurion NV announces 2021 Full Year Results and 2022 Outlook Oxurion NV
23-Feb-2022 TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients TargED Biopharmaceuticals
23-Feb-2022 Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2021 Results Presentation and Webcast Nordic Nanovector ASA
23-Feb-2022 AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers AstraZeneca
23-Feb-2022 Gendius initiates GP data study to develop enhanced risk prediction tools for diabetes Gendius
23-Feb-2022 CSL Behring joins the ABPI CSL Behring